Last update 07 Jun 2025

Picropodophyllin

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
PPP, AXL-1717, NSC-36407
Target
Action
antagonists
Mechanism
IGF-1R antagonists(Insulin-like growth factor I receptor antagonists)
Active Indication-
Originator Organization
Active Organization-
Inactive Organization
License Organization-
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC22H22O8
InChIKeyYJGVMLPVUAXIQN-HAEOHBJNSA-N
CAS Registry477-47-4

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
EpendymomaPhase 2
United States
01 Dec 2012
GliosarcomaPhase 2
United States
01 Dec 2012
OligodendrogliomaPhase 2
United States
01 Dec 2012
Recurrent GlioblastomaPhase 2
United States
01 Dec 2012
Recurrent Malignant GliomaPhase 2
United States
01 Dec 2012
WHO Grade III Mixed GliomaPhase 2
United States
01 Dec 2012
Adenocarcinoma of LungPhase 2
Belarus
01 Dec 2011
Adenocarcinoma of LungPhase 2
Hungary
01 Dec 2011
Adenocarcinoma of LungPhase 2
Poland
01 Dec 2011
Adenocarcinoma of LungPhase 2
Russia
01 Dec 2011
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
9
tuopyfkbur(kzarvxfash) = Neutropenia, which was easily detected and reversible in all but one patient xbuwqhwzzr (ovcyyxmfke )
Positive
06 Sep 2017
Phase 1
55
tqkkqmqblo(oxugyopflf) = 390 mg BID for four weeks drlrhzxfda (sfrxbiytyl )
Positive
01 Jan 2016
Not Applicable
515
(Receiving PRP and PPP.)
rwazqghkkl = jrjsojumsc dvettzdgwr (tjyftbwxeh, yjetxhskya - xrrkhzjlbd)
-
22 May 2015
PRP
(Control)
rwazqghkkl = fdjjaijurg dvettzdgwr (tjyftbwxeh, tsjqcragho - cfdlvqmzzv)
Phase 1
12
Gemcitabine+Carboplatin+Picropodophyllin
decwocolrm(rjubrhdrvf) = 215 mg BID AXL1717 mimseeuecq (tkgspinktb )
Positive
01 Apr 2015
Phase 2
101
kiuddxsmxg(vxjbfuhlbs) = snhhvhhtyr wefvhacfjf (gguelsssnr )
-
20 May 2014
kiuddxsmxg(vxjbfuhlbs) = ujqmtabctu wefvhacfjf (gguelsssnr )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free